AMBER VICKERS: Open Payments
NPI 1114964616 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 13 payments from 9 companies in 2025. Trend: 2023 $232 · 2024 $397 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $76 |
| Exact Sciences Corporation | 2 | $43 |
| Novo Nordisk Inc | 2 | $38 |
| Dexcom, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: UBRELVY, Cologuard Collection Kit, Dexcom G6 Transmitter, PREVNAR 20, ELIQUIS, Wegovy, MOUNJARO, QULIPTA.
Industry payments across ID — which companies pay providers there.
